Format

Send to

Choose Destination
Leukemia. 2018 Aug;32(8):1795-1882. doi: 10.1038/s41375-017-0001-0. Epub 2018 Feb 15.

Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.

Author information

1
Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
2
Department of Veterinary Medicine, University of Maryland, College Park, MD, USA.
3
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK.
4
Molecular Biology Laboratory, Boldrini Children's Center, Campinas, Brazil.
5
Department of Genetics, Evolution and Bioagents, Institute of Biology, State University of Campinas, Campinas, Brazil.
6
Genomics Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc. (LBR), Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD, USA.
7
Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda, MD, USA.
8
Center for Cancer Research Collaborative Bioinformatics Resource, NCI, NIH, Bethesda, MD, USA.
9
Protein Expression Laboratory/RAS Reagents Core, NCI RAS Initiative, LBR, FNLCR, Frederick, MD, USA.
10
Leukemia Biology Section, Genetics Branch, NCI, NIH, Bethesda, MD, USA.
11
Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA. durums@mail.nih.gov.
PMID:
29535426
DOI:
10.1038/s41375-017-0001-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center